Netherlands Cancer Institute

The competition was established in 2015 to fund studies addressing the biggest challenges in cancer research.

Using exome sequencing, researchers unearthed apparent anti-PD-1 resistance mutations in three of four individuals treated for metastatic melanoma.

The seven-parameter proposal potentially offers a way to assess how the immune system and a cancer interact on a broader level in order to better guide treatment.

NEW YORK (GenomeWeb News) – A group of Dutch-led research partners will use a €1.2 million ($1.5 million) grant awarded under a collaboration with Stand Up 2 Cancer (SU2C) to fund a genomics-based project seeking to use tumor profiles to predict patient response to cancer treatments.

"We will use multiple 'omics' technologies to ask which kinase signaling pathways are activated in colon cancer," an Agendia spokesperson said of the collaboration, which will also provide independent validation of the company's ColoPrint colon cancer recurrence test.

The partners will use an integrated approach combining genomics and proteomics to better understand colorectal cancer biology.

The partners will seek to identify specific colorectal cancer subtypes in order to develop targeted therapies.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.